PROOF-HD: Phase III trial of oral S1R agonist pridopidine for the treatment of Huntington’s disease Published 2022-10-10 Download video MP4 360p Download video MP4 720p Recommendations 01:40 The role of risvodetinib in the treatment of Parkinson's disease & other CNS diseases 02:11 uniQure's miQURE Technology 12:21 Introduction of New Council Members, NHGRI Staff, Liaisons and Guests (NACHGR Sep 2023) 03:19 The Impact of HD Chorea on: Personal Life 01:11 Huntington-Krankheit // Prilenia Therapeutics - Wie geht es weiter? What comes next? 1:35:09 Ebola Survivor - Dr. Ian Crozier 26:44 The Story of Sigma-1R Identification as Potential Drug Target for The Treatment of... 01:45 It's an exciting time for Huntington's disease research 02:52 Phase II trial of SAGE-718 for the treatment of cognitive impairment in Huntington’s disease 08:13 The potential of ambroxol in Parkinson’s disease dementia: Phase II trial results 02:43 Disease-modifying trials for Huntington’s disease 32:07 What are the Different Types of Antidepressants AND How Do They Work? | Mechanisms of Action 02:00 2-Minute Neuroscience: Dopamine 1:05:14 Prilenia | Family voices | Huntington's disease 01:22 New hopes for the treatment of Parkinson's disease 11:46 Can Genetic Testing Point You to the Best Mental Health Treatment? 33:39 Transcranial Magnetic Stimulation: A New Treatment Approach for Psychiatric Disorders 03:35 Phase II PIOVT-HD trial of PTC518 in early Huntington's disease 02:06 Treating cognitive and psychiatric symptoms in Huntington’s disease 15:40 Seroquel (Quetiapine) What you NEED to Know! Similar videos 03:03 Pridopidine application beyond Huntington’s disease 05:08 PTC518: oral splicing modifier under investigation for the treatment of Huntington’s disease 03:12 PROOF-HD Study Enrolling Huntington Disease Patients 03:25 Pridopidine rescues BDNF transport in a Huntington’s disease brain-on-a-chip model 17:58 Prilenia Proof HD Update: Dr Michael Hayden 02:54 Somatic expansion as a novel therapeutic approach for Huntington’s disease 02:22 The role of post-translational modifications in Huntington's disease More results